Five patients were identified by medical records and fluorescein angio
graphy as having developed central serous chorioretinopathy (CSC) duri
ng corticosteroid treatment. These five and 28 previously reported cor
ticosteroid-induced CSC occurrences were studied to clarify the differ
ences between idiopathic CSC and corticosteroid-induced CSC. Nine prev
iously reported occurrences of corticosteroid-induced multiple posteri
or pigment epitheliopathy (MPPE) were also reviewed. Corticosteroid-in
duced CSC patients were older and less male-dominant; in MPPE, female
patients predominated and most had bilateral involvement, The onset of
CSC was within 70 days of corticosteroid administration in the short
latency group, and more than 6 months after administration in the prol
onged latency group. Daily doses of prednisolone usually exceeded 20 m
g in the short latency group and was less than 20 mg in the prolonged
latency group, Immunosuppressive agents such as cyclophosphamide were
related to a lower daily dose at onset. (C) 1997 Japanese Ophthalmolog
ical Society.